Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01055847 · ClinicalTrials.gov registry record · Phase 2

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

A Phase 2 study of Cystic Fibrosis and Pseudomonas Aeruginosa, sponsored by Gilead Sciences.

Completed
Registry status
Phase 2
Development phase
105
Enrollment target
20
Study locations

NCT01055847 is a Phase 2 study of Cystic Fibrosis and Pseudomonas Aeruginosa that has completed, run by Gilead Sciences. The registered enrollment target is 105 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (41% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01055847, a Phase 2 study of Cystic Fibrosis and Pseudomonas Aeruginosa, has completed, sponsored by Gilead Sciences.

COMPLETED
Registry status
Phase 2
Development phase
105 participants
Enrollment target
20
Study locations

Study Summary

This is multicenter placebo-controlled study evaluating the safety and efficacy of AI at two dosage levels compared to placebo in CF patients with P. aeruginosa lung infection.

Conditions Studied

Cystic Fibrosis Pseudomonas Aeruginosa Lung Infection CF

Interventions

  • DRUG Placebo
  • DRUG Aztreonam for Inhalation (AI)

Study Locations (20)

California

  • - Los Angeles
  • - Orange
  • - San Diego
  • - Stanford

Ohio

  • - Cleveland
  • - Columbus
  • - Dayton

Florida

  • - Gainsville
  • - Orlando

Colorado

  • - Denver

Massachusetts

  • - Boston

Michigan

  • - Ann Arbor

Nebraska

  • - Omaha

North Carolina

  • - Chapel Hill

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2003-06
Est. Completion 2004-09
Phase Phase 2

Sponsor

Gilead Sciences

504 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01055847

The ClinicalTrials.gov registry entry for NCT01055847 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (41% lower). The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01055847 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Ohio, Florida.

Frequently Asked Questions

What is clinical trial NCT01055847 about?

NCT01055847 is a clinical study titled "Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection". This is multicenter placebo-controlled study evaluating the safety and efficacy of AI at two dosage levels compared to placebo in CF patients with P. aeruginosa lung infection.

What is the current status of trial NCT01055847?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2003-06. Estimated completion is 2004-09.

What conditions does trial NCT01055847 study?

This clinical trial studies the following conditions: Cystic Fibrosis, Pseudomonas Aeruginosa, Lung Infection, CF.

What interventions are being tested in trial NCT01055847?

The interventions under investigation include: Placebo (DRUG), Aztreonam for Inhalation (AI) (DRUG).

Who is sponsoring clinical trial NCT01055847?

This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01055847 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cystic Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cystic Fibrosis

All registered trials for this condition

Pseudomonas Aeruginosa

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.